143 related articles for article (PubMed ID: 21149487)
1. Improved detection of regional melanoma metastasis using 18F-6-fluoro-N-[2-(diethylamino)ethyl] pyridine-3-carboxamide, a melanin-specific PET probe, by perilesional administration.
Denoyer D; Potdevin T; Roselt P; Neels OC; Kirby L; Greguric I; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2011 Jan; 52(1):115-22. PubMed ID: 21149487
[TBL] [Abstract][Full Text] [Related]
2. High-contrast PET of melanoma using (18)F-MEL050, a selective probe for melanin with predominantly renal clearance.
Denoyer D; Greguric I; Roselt P; Neels OC; Aide N; Taylor SR; Katsifis A; Dorow DS; Hicks RJ
J Nucl Med; 2010 Mar; 51(3):441-7. PubMed ID: 20150254
[TBL] [Abstract][Full Text] [Related]
3. [
Rizzo-Padoin N; Chaussard M; Vignal N; Kotula E; Tsoupko-Sitnikov V; Vaz S; Hontonnou F; Liu WQ; Poyet JL; Vidal M; Merlet P; Hosten B; Sarda-Mantel L
Nucl Med Biol; 2016 Dec; 43(12):773-780. PubMed ID: 27693672
[TBL] [Abstract][Full Text] [Related]
4. 3'-18F-fluoro-3'-deoxy-L-thymidine: a new tracer for staging metastatic melanoma?
Cobben DC; Jager PL; Elsinga PH; Maas B; Suurmeijer AJ; Hoekstra HJ
J Nucl Med; 2003 Dec; 44(12):1927-32. PubMed ID: 14660718
[TBL] [Abstract][Full Text] [Related]
5. Ultrasensitive detection of malignant melanoma using PET molecular imaging probes.
Pyo A; Kim DY; Kim H; Lim D; Kwon SY; Kang SR; Kim HS; Bom HS; Min JJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(23):12991-12999. PubMed ID: 32439710
[TBL] [Abstract][Full Text] [Related]
6. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.
Clark PB; Soo V; Kraas J; Shen P; Levine EA
Arch Surg; 2006 Mar; 141(3):284-8. PubMed ID: 16549694
[TBL] [Abstract][Full Text] [Related]
7. Initial assessment of positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-D-glucose in the imaging of malignant melanoma.
Gritters LS; Francis IR; Zasadny KR; Wahl RL
J Nucl Med; 1993 Sep; 34(9):1420-7. PubMed ID: 8355058
[TBL] [Abstract][Full Text] [Related]
8. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of silent metastases from malignant melanoma.
Eigtved A; Andersson AP; Dahlstrøm K; Rabøl A; Jensen M; Holm S; Sørensen SS; Drzewiecki KT; Højgaard L; Friberg L
Eur J Nucl Med; 2000 Jan; 27(1):70-5. PubMed ID: 10654150
[TBL] [Abstract][Full Text] [Related]
9. Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.
Wagner JD; Schauwecker D; Davidson D; Logan T; Coleman JJ; Hutchins G; Love C; Wenck S; Daggy J
Cancer; 2005 Aug; 104(3):570-9. PubMed ID: 15977211
[TBL] [Abstract][Full Text] [Related]
10. [PET scanning for malignant melanoma and positive sentinel node diagnostics].
Horn J; Sjøstrand H; Lock-Andersen J; Loft A
Ugeskr Laeger; 2010 Apr; 172(15):1126-30. PubMed ID: 20427004
[TBL] [Abstract][Full Text] [Related]
11. Preoperative 18F-FDG-PET/CT imaging and sentinel node biopsy in the detection of regional lymph node metastases in malignant melanoma.
Singh B; Ezziddin S; Palmedo H; Reinhardt M; Strunk H; Tüting T; Biersack HJ; Ahmadzadehfar H
Melanoma Res; 2008 Oct; 18(5):346-52. PubMed ID: 18781133
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of high-risk melanoma: comparison of [18F]FDG PET and high-dose 67Ga SPET.
Kalff V; Hicks RJ; Ware RE; Greer B; Binns DS; Hogg A
Eur J Nucl Med Mol Imaging; 2002 Apr; 29(4):506-15. PubMed ID: 11914889
[TBL] [Abstract][Full Text] [Related]
13. F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mm.
Maubec E; Lumbroso J; Masson F; Suciu V; Kolb F; Mamelle G; Cavalcanti A; Boitier F; Spatz A; Aupérin A; Leboulleux S; Avril MF
Melanoma Res; 2007 Jun; 17(3):147-54. PubMed ID: 17505260
[TBL] [Abstract][Full Text] [Related]
14.
Pyo A; Kim HS; Kim HS; Yun M; Kim DY; Min JJ
J Nucl Med; 2019 Jul; 60(7):924-929. PubMed ID: 30552204
[TBL] [Abstract][Full Text] [Related]
15. Whole-body 18 FDG PET/CT imaging for lymph node and metastatic staging of conjunctival melanoma.
Kurli M; Chin K; Finger PT
Br J Ophthalmol; 2008 Apr; 92(4):479-82. PubMed ID: 18369064
[TBL] [Abstract][Full Text] [Related]
16. Early detection and longitudinal monitoring of experimental primary and disseminated melanoma using [¹⁰F]ICF01006, a highly promising melanoma PET tracer.
Rbah-Vidal L; Vidal A; Besse S; Cachin F; Bonnet M; Audin L; Askienazy S; Dollé F; Degoul F; Miot-Noirault E; Moins N; Auzeloux P; Chezal JM
Eur J Nucl Med Mol Imaging; 2012 Sep; 39(9):1449-61. PubMed ID: 22707183
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node excision and PET-CT in the initial stage of malignant melanoma: a retrospective analysis of 61 patients with malignant melanoma in American Joint Committee on Cancer stages I and II.
Klode J; Dissemond J; Grabbe S; Hillen U; Poeppel T; Boeing C
Dermatol Surg; 2010 Apr; 36(4):439-45. PubMed ID: 20187901
[TBL] [Abstract][Full Text] [Related]
18. Melanoma imaging with highly specific PET probes: ready for prime time?
Minn H; Vihinen P
J Nucl Med; 2011 Jan; 52(1):5-7. PubMed ID: 21149485
[No Abstract] [Full Text] [Related]
19. Value of tumour marker S-100B in melanoma patients: a comparison to 18F-FDG PET and clinical data.
Reinhardt MJ; Kensy J; Frohmann JP; Willkomm P; Reinhold U; Grünwald F; Biersack HJ; Bender H
Nuklearmedizin; 2002 Jun; 41(3):143-7. PubMed ID: 12109034
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
